CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($) shares in Millions, $ in Millions	Total	Common Stock	Treasury Shares	Paid-In Capital	Accumulated Other Comprehensive Income	Retained Earnings
Beginning balance (in shares) at Dec. 31, 2022		768
Beginning balance (in shares) at Dec. 31, 2022			0
Balance at beginning of period at Dec. 31, 2022	$ 12,659	$ 77	$ 0	$ 7,933	$ 13	$ 4,636
Increase (Decrease) in Stockholders' Equity
Net income	677					677
Stock amortization and vesting	13			13
Conversion of Cimarex redeemable preferred stock	3			3
Common stock repurchases (in shares)			11
Common stock repurchases	(271)		$ (271)
Common stock retirements (in shares)		(11)	(11)
Common stock retirements	0	$ (1)	$ (271)	(270)
Common stock cash dividends	(438)					(438)
Ending balance (in shares) at Mar. 31, 2023		757
Ending balance (in shares) at Mar. 31, 2023			0
Balance at end of period at Mar. 31, 2023	12,643	$ 76	$ 0	7,679	13	4,875
Beginning balance (in shares) at Dec. 31, 2023		751
Beginning balance (in shares) at Dec. 31, 2023			0
Balance at beginning of period at Dec. 31, 2023	13,039	$ 75	$ 0	7,587	11	5,366
Increase (Decrease) in Stockholders' Equity
Net income	352
Stock amortization and vesting	15			15
Common stock repurchases (in shares)			6
Common stock repurchases	(157)		$ (157)
Common stock retirements (in shares)		(6)	(6)
Common stock retirements	0	$ 0	$ (157)	(157)
Common stock cash dividends	(160)					(160)
Ending balance (in shares) at Mar. 31, 2024		745
Ending balance (in shares) at Mar. 31, 2024			0
Balance at end of period at Mar. 31, 2024	$ 13,089	$ 75	$ 0	$ 7,445	$ 11	$ 5,558